Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
70 /100
HIGH RISK
Score updated Oct 13, 2026

ANTX — AN2 Therapeutics, Inc. Dilution Risk Tracker

Track ANTX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ANTX — Get alerts when the score changes →

As of October 13, 2026, AN2 Therapeutics, Inc. (ANTX) has a DilutionWatch DilutionScore of 70/100, rated HIGH dilution risk. AN2 Therapeutics, Inc. has a market capitalization of $162.27M, 37.74M shares outstanding, 52 institutional holders tracked. Stored dilution-related fields include shelf registration capacity of $300.00M, ATM program capacity of $80.00M, 2.95M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
100
💰 Cash Runway
65
📊 Float Risk
50
⚠️ Warrant Exposure
30
🔄 Convertible Debt
40

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 33%
💰 Capital Raise model 53%
• Under 12 months cash (10mo)
• Active shelf registration ($300M, 185% of market cap)
📜 Warrant Exercise model 15%
• Warrant overhang: 7.8% of shares outstanding
📉 Score Deterioration model 10%
• Score in HIGH risk zone (70/100)
🔔 Track ANTX — Get forecast alerts →

Market Data

Market Cap$162.27M
Shares Outstanding37.74M
Float17.02M
Cash$44.32M
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore70/100DilutionWatch score record
Shares Outstanding37.74MVerified float table or market cache
Public Float17.02MVerified float table or market cache
Market Cap$162.27MMarket data cache
Cash Runway10.2 monthsDilutionWatch score inputs
Shelf Capacity$300.00MSEC-derived dilution fields
ATM Capacity$80.00MSEC-derived dilution fields
Outstanding Warrants2.95MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 2, 424B3 1, 424B5 1, EFFECT 1, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 205.4% shares (2026Q1 vs prior)
52 institutional holders · 27.64M shares
#1 Vivo Capital, LLC 6.31M shares
#2 Commodore Capital LP 2.33M shares
#3 MILLENNIUM MANAGEMENT LLC 2.22M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest2.49M
Days to Cover9.5
% of Float14.6%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-03-17
xbrl XBRL CONVERTIBLE 2024-03-29
EFFECT EFFECT 2026-04-20
424B3 ATM 2026-04-20
424B5 ATM 2026-04-20
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual ANTX Dilution Snapshot

AN2 Therapeutics, Inc. (ANTX) has a DilutionScore of 70/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

ANTX's DilutionScore is currently 70/100 (High risk), with 3 score changes tracked over 89 days. The score deteriorated from 71/100 (High risk).

Period Score Risk Level Duration
Sep 28 – Oct 13, 202670/100HIGH16 days
Aug 22 – Sep 27, 202671/100HIGH37 days
Aug 14 – Aug 21, 202667/100HIGH7 days
Jul 16 – Aug 13, 202664/100HIGH29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

ANTX shares outstanding have increased 31.4% from 27.40M (Mar 2026) to 36.02M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 14, 202636.02M17.02M▲ 0.21%
Apr 26, 202636.00M16.98M▲ 0.03%
Apr 18, 202635.95M16.98M▲ 0.14%
Apr 13, 202635.95M16.95M▼ 0.03%
Mar 25, 202635.94M16.96M▲ 53.56%
Mar 24, 202635.94M11.04M▼ 0.01%
Mar 19, 202627.40M11.05M▲ 2.70%
Mar 17, 202627.40M10.76M▼ 33.39%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track ANTX Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment ANTX files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking ANTX — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for ANTX
ANTX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.